This website uses cookies to enhance the user experience.
AB

Anders Brekke1974

Shareholdings
3
7
Norway Business roles
18

Roles

Management

NameRoleTotal operating incomeTotal equityShares
A
AB-FARMA AS
Managing Director/CEO
-
30,000
100 %
directly
F
FROGNER APOTEK SØRUM AS
Managing Director/CEO
19,785,301
1,306,527
50 %
directly
M
MARIKOLLEN TORG APOTEK AS
Managing Director/CEO
17,410,976
894,807
33.33 %
indirectly
K
KARIHAUGEN APOTEK AS
Managing Director/CEO
23,331,518
1,027,085
33.33 %
indirectly
F
FARMAGRUPPEN AS
Managing Director/CEO
704,798
8,990,099
33.33 %
directly
A
ANDERS BREKKE
Managing Director/CEO
-
-
-
K
KB KLØFTA APOTEK AS
Managing Director/CEO
-
-
-

Boards

NameRoleTotal operating incomeTotal equityShares
A
AB-FARMA AS
Chairman
-
30,000
100 %
directly
F
FROGNER APOTEK SØRUM AS
Board Member
19,785,301
1,306,527
50 %
directly
F
FARMAGRUPPEN AS
Board Member
704,798
8,990,099
33.33 %
directly
M
MARIKOLLEN TORG APOTEK AS
Board Member
17,410,976
894,807
33.33 %
indirectly
K
KARIHAUGEN APOTEK AS
Board Member
23,331,518
1,027,085
33.33 %
indirectly
V
VESTLI APOTEK AS
Board Member
15,305,925
-1,914,510
17 %
indirectly
A
ANDERS BREKKE
Holder
-
-
-
F
FROGNER NÆRINGSFORUM
Contact Person
-
-
-
V
VEAR APOTEK AS
Board Member
20,060,836
527,765
-
K
KB KLØFTA APOTEK AS
Board Member
-
-
-
Last update: Feb 28, 2025

Shares owned by Anders Brekke

NameShare classTotal operating incomeTotal equityShare
A
AB-FARMA AS
Ordinære aksjer
0
30,000
100 %
directly
F
FROGNER APOTEK SØRUM AS
Ordinære aksjer
19,785,301
1,306,527
50 %
directly
F
FARMAGRUPPEN AS
Ordinære aksjer
704,798
8,990,099
33.33 %
directly
B
BORGEÅSEN APOTEK AS
16,260,393
418,419
33.33 %
indirectly
F
FALKUM APOTEK AS
19,306,728
600,606
33.33 %
indirectly
H
HELGEROA APOTEK AS
17,397,442
451,797
33.33 %
indirectly
M
MARIKOLLEN TORG APOTEK AS
17,410,976
894,807
33.33 %
indirectly
K
KARIHAUGEN APOTEK AS
23,331,518
1,027,085
33.33 %
indirectly
V
VESTLI APOTEK AS
15,305,925
-1,914,510
17 %
indirectly
S
STRIDSKLEV APOTEK AS
30,079,490
289,282
17 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024